Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines

Sponsor
University of Patras (Other)
Overall Status
Completed
CT.gov ID
NCT04954651
Collaborator
(none)
1,000
1
8.7
115.3

Study Details

Study Description

Brief Summary

Patients who voluntarily visit vaccination centers in Greece against COVID-19 are recruited and their immunization levels against Sars-Cov2 are assesed by measurement of the levels of serum antibodies against Sars-cov-2 before vaccination and in time intervals up to 6-9 months post-vaccination (indicatively 0-1-3-6-9 months post-vaccination).

Condition or Disease Intervention/Treatment Phase
  • Biological: Approved vaccines against Sars-Cov2

Study Design

Study Type:
Observational
Actual Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received European Union (EU) -Approved COVID-19 Vaccines
Actual Study Start Date :
Jul 7, 2021
Actual Primary Completion Date :
Mar 28, 2022
Actual Study Completion Date :
Mar 28, 2022

Arms and Interventions

Arm Intervention/Treatment
VAC

Vaccinated subject against Sars-Cov2

Biological: Approved vaccines against Sars-Cov2
Subjects who voluntarily are vaccinated against Sars-Cov-2 with any of the approved vaccines by EU

Outcome Measures

Primary Outcome Measures

  1. Antibody titer against Sars-Cov2 [0-9 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subjects who voluntarily receive COVID-19 vaccination
Exclusion Criteria:
  • Patients who do not complete their vaccination

  • Patients who do not provide info on their health status

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital of Patras Patras Greece 26504

Sponsors and Collaborators

  • University of Patras

Investigators

  • Principal Investigator: Ioannis Habeos, MD, PhD, University of Patras

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ioannis Habeos, Professor, University of Patras
ClinicalTrials.gov Identifier:
NCT04954651
Other Study ID Numbers:
  • 99-25/2/2021
First Posted:
Jul 8, 2021
Last Update Posted:
Jun 6, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ioannis Habeos, Professor, University of Patras
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 6, 2022